Published in Transplantation on September 15, 1995
Enteral drug absorption in patients with short small bowel : a review. Clin Pharmacokinet (2004) 0.81
Diagnosis and management of late complications after liver transplantation. Arch Dis Child (1999) 0.75
Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol (1995) 4.36
Factors influencing the natural history of colorectal liver metastases. Lancet (1994) 3.61
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol (2003) 3.25
Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab (2001) 2.98
The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun (2001) 2.89
Homotoxicology--a review of randomised clinical trials. Eur J Clin Pharmacol (2004) 2.67
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci U S A (2001) 2.50
Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite. FASEB J (2001) 2.43
Molecular diagnosis of the Prader-Willi and Angelman syndromes by detection of parent-of-origin specific DNA methylation in 15q11-13. Hum Genet (1992) 2.41
Synthesis of the Escherichia coli K-12 nucleoid-associated DNA-binding protein H-NS is subjected to growth-phase control and autoregulation. Mol Microbiol (1993) 2.38
Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol (1993) 2.35
Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol (1999) 2.33
Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol (1996) 2.27
Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty. Circulation (2001) 2.26
Biosynthesis of endothelium-derived relaxing factor: a cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem Biophys Res Commun (1989) 2.25
Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J (1995) 2.15
Creationists evolve new strategy. Science (1996) 2.05
Cultural variations in mental health. Med J Aust (1992) 2.04
SarS, a SarA homolog repressible by agr, is an activator of protein A synthesis in Staphylococcus aureus. Infect Immun (2001) 2.02
Adverse events of herbal food supplements for body weight reduction: systematic review. Obes Rev (2005) 1.93
[Generation Y : recruitment, retention and development]. Anaesthesist (2011) 1.86
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.81
Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Mol Cell Biol (1995) 1.76
Nonlinear analysis of heart rate and respiratory dynamics. IEEE Eng Med Biol Mag (1997) 1.75
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry (2008) 1.71
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
Functional magnetic resonance imaging in conscious animals: a new tool in behavioural neuroscience research. J Neuroendocrinol (2006) 1.69
Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology (1998) 1.68
The risk of rebleeding from ruptured intracranial aneurysms. J Neurosurg (1987) 1.68
The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J Biol Chem (1994) 1.61
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. J Pharmacol Exp Ther (2008) 1.60
Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg (1999) 1.59
Hosts as ecological traps for the vector of Lyme disease. Proc Biol Sci (2009) 1.59
The Anesthesia Preoperative Evaluation Clinic (APEC): a prospective randomized controlled trial assessing impact on consultation time, direct costs, patient education and satisfaction with anesthesia care. Minerva Anestesiol (2010) 1.59
Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract. J Urol (2008) 1.56
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood (1999) 1.55
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology (2005) 1.50
Mobile stroke unit for diagnosis-based triage of persons with suspected stroke. Neurology (2012) 1.49
Powder diffraction from a continuous microjet of submicrometer protein crystals. J Synchrotron Radiat (2008) 1.49
WHO surveillance programme for control of foodborne infections and intoxications: preliminary results and trends across greater Europe. World Health Organization. J Infect (2001) 1.48
A survey of hantavirus antibody in small-mammal populations in selected United States National Parks. Am J Trop Med Hyg (1998) 1.47
Vascular tracheobronchial compression syndromes-- experience in surgical treatment and literature review. Thorac Cardiovasc Surg (2000) 1.47
Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. J Biol Chem (1996) 1.45
[Synthesis of delta-aminolevulinic acid and chlorophyll during illumination of etiolated Euglena gracilis]. Biochim Biophys Acta (1973) 1.44
[Resection of colorectal liver metastases. What prognostic factors determine patient selection?]. Chirurg (2001) 1.44
Aspects of MMR. Survey shows that some homoeopaths and chiropractors advise against MMR. BMJ (2002) 1.43
Relation of stressors and depressive symptoms to clinical progression of viral illness. Am J Psychiatry (1996) 1.43
Healthy baby second-hand smoke study: project brief. Tob Control (2000) 1.43
[Primary upper urinary tract tumors and subsequent location in the bladder]. Prog Urol (2009) 1.42
A phase II study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric carcinoma. J Cancer Res Clin Oncol (1998) 1.42
Need for caesarean sections in west Africa. Lancet (2002) 1.42
Treatment of colorectal liver metastases. Br J Surg (1999) 1.41
[Asynchronous implantation of a penile prosthesis (AMS 700) in patients with an artificial urinary sphincter (AMS 800): what functional outcomes can we expect from the AMS 1500?]. Prog Urol (2012) 1.40
Emergence and scattering of multiple neurofibromatosis (NF1)-related sequences during hominoid evolution suggest a process of pericentromeric interchromosomal transposition. Hum Mol Genet (1997) 1.40
[Erectile dysfunction after radical prostatectomy: pathophysiology, evaluation and treatment]. Prog Urol (2009) 1.39
[Analysis of the bibliometrics score of surgical department from the academic hospitals of Paris: what is the rank of urology?]. Prog Urol (2011) 1.39
Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy. Clin Lab Haematol (2005) 1.39
Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem (1995) 1.37
[Quality comparison of modified neurolept-, balanced and intravenous anesthesia. 1. Study design and patient analysis of the Krefelder study 1992]. Anaesthesist (1995) 1.37
Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol (1998) 1.37
Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry. J Biol Chem (1997) 1.35
Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem (1993) 1.35
Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis (2004) 1.33
A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J Biol Chem (1998) 1.33
Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am (1989) 1.33
Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Clin Cancer Res (1997) 1.32
Metabolism of pyruvate and L-lactate by rat adipose tissue. J Biol Chem (1969) 1.29
Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole. Neuropharmacology (1994) 1.28
Idiopathic weight reduction in mice deficient in the high-mobility-group transcription factor Sox8. Mol Cell Biol (2001) 1.28
Protein tyrosine nitration in cytokine-activated murine macrophages. Involvement of a peroxidase/nitrite pathway rather than peroxynitrite. J Biol Chem (2001) 1.27
Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins. Dig Dis Sci (2002) 1.26
Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles. Hepatology (1984) 1.25
Enzymic degradation of isotopically labeded compounds. II. Glucose labeled with 14C and tritium. Anal Biochem (1970) 1.24
The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J Virol (2011) 1.23
[Primary results and long-term outcome of an ambulatory, cardiac rehabilitation model (phase II) after myocardial infarct, dilatation treatment and heart operation]. Z Kardiol (1997) 1.21
Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data. Neuroimage (2001) 1.21
Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate. J Biol Chem (1993) 1.20
Sensitive and selective determination of picogram amounts of ciprofloxacin and its metabolites in biological samples using high-performance liquid chromatography and photothermal post-column derivatization. J Chromatogr (1987) 1.19
Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase. J Biol Chem (2000) 1.19
Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia (2007) 1.18
Measurement of local cerebral protein synthesis in vivo: influence of recycling of amino acids derived from protein degradation. Proc Natl Acad Sci U S A (1988) 1.18
Dityrosine formation outcompetes tyrosine nitration at low steady-state concentrations of peroxynitrite. Implications for tyrosine modification by nitric oxide/superoxide in vivo. J Biol Chem (2000) 1.17
External stabilization of long-segment tracheobronchomalacia guided by intraoperative bronchoscopy. Ann Thorac Surg (1997) 1.17
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience. Radiology (1998) 1.17
Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.16
Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites. Biochemistry (1996) 1.16
Contulakin-G, an O-glycosylated invertebrate neurotensin. J Biol Chem (1999) 1.16
A controlled study of microsurgical versus standard lumbar discectomy. Br J Neurosurg (1996) 1.16
Radical operations for carcinoma of the gallbladder: present status in Germany. World J Surg (1991) 1.15
Is it possible to verify directly a proton-treatment plan using positron emission tomography? Radiother Oncol (1993) 1.14
Brain nitric oxide synthase is a haemoprotein. Biochem J (1992) 1.13
SPR-based fragment screening: advantages and applications. Curr Top Med Chem (2007) 1.13
Zinc gluconate lozenges for common cold. A double-blind clinical trial. Dan Med Bull (1990) 1.12
Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res (1994) 1.11
Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Br J Pharmacol (1996) 1.11
Na(+)/Ca(2+) exchange facilitates Ca(2+)-dependent activation of endothelial nitric-oxide synthase. J Biol Chem (1999) 1.09
Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation. J Biol Chem (1994) 1.09